169 related articles for article (PubMed ID: 27348518)
21. High Normal Blood Pressure and Left Ventricular Hypertrophy Echocardiographic Findings From the PAMELA Population.
Cuspidi C; Facchetti R; Bombelli M; Tadic M; Sala C; Grassi G; Mancia G
Hypertension; 2019 Mar; 73(3):612-619. PubMed ID: 30612493
[TBL] [Abstract][Full Text] [Related]
22. Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population.
Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
Am J Hypertens; 2017 Mar; 30(3):279-285. PubMed ID: 28096148
[TBL] [Abstract][Full Text] [Related]
23. The Pamela study: main findings and perspectives.
Bombelli M; Toso E; Peronio M; Fodri D; Volpe M; Brambilla G; Facchetti R; Sega R; Grassi G; Mancia G
Curr Hypertens Rep; 2013 Jun; 15(3):238-43. PubMed ID: 23609611
[TBL] [Abstract][Full Text] [Related]
24. Risk of new-onset metabolic syndrome associated with white-coat and masked hypertension: data from a general population.
Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
J Hypertens; 2018 Sep; 36(9):1833-1839. PubMed ID: 29965885
[TBL] [Abstract][Full Text] [Related]
25. Targeting persistent normal left ventricular geometry in the general population: a 25-year follow-up study.
Cuspidi C; Facchetti R; Seravalle G; Tadic M; Mancia G; Grassi G
J Hypertens; 2021 May; 39(5):952-960. PubMed ID: 33323911
[TBL] [Abstract][Full Text] [Related]
26. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study.
Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Grassi G; Sega R
Hypertension; 2007 Jun; 49(6):1265-70. PubMed ID: 17452502
[TBL] [Abstract][Full Text] [Related]
27. Long-term risk of sustained hypertension in white-coat or masked hypertension.
Mancia G; Bombelli M; Facchetti R; Madotto F; Quarti-Trevano F; Polo Friz H; Grassi G; Sega R
Hypertension; 2009 Aug; 54(2):226-32. PubMed ID: 19564548
[TBL] [Abstract][Full Text] [Related]
28. Defining blood pressure goals: is it enough to manage total cardiovascular risk?
Mancia G
J Hypertens Suppl; 2009 Jul; 27(5):S3-8. PubMed ID: 19587552
[TBL] [Abstract][Full Text] [Related]
29. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: the PAMELA study.
Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
J Hypertens; 2016 Jul; 34(7):1423-31. PubMed ID: 27136313
[TBL] [Abstract][Full Text] [Related]
31. Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study.
Cuspidi C; Sala C; Casati A; Bombelli M; Grassi G; Mancia G
Hypertens Res; 2017 Apr; 40(4):329-335. PubMed ID: 27853165
[TBL] [Abstract][Full Text] [Related]
32. Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy.
Bombelli M; Vanoli J; Cuspidi C; Dell'Oro R; Facchetti R; Mancia G; Grassi G
J Clin Hypertens (Greenwich); 2023 Apr; 25(4):343-349. PubMed ID: 36824023
[TBL] [Abstract][Full Text] [Related]
33. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
[TBL] [Abstract][Full Text] [Related]
34. Office and Out-of-Office Blood Pressure Changes Over a Quarter of Century: Findings From the PAMELA Study.
Cuspidi C; Facchetti R; Dell'Oro R; Quarti-Trevano F; Tadic M; Mancia G; Grassi G
Hypertension; 2020 Sep; 76(3):759-765. PubMed ID: 32755470
[TBL] [Abstract][Full Text] [Related]
35. Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction.
Mancia G; Facchetti R; Seravalle G; Cuspidi C; Corrao G; Grassi G
Hypertension; 2021 Feb; 77(2):640-649. PubMed ID: 33390055
[TBL] [Abstract][Full Text] [Related]
36. Association between Berlin questionnaire index and blood pressure, organ damage and metabolic profilein a general population.
Vanoli J; Dell'Oro R; Facchetti R; Bombelli M; Mancia G; Grassi G
J Clin Hypertens (Greenwich); 2022 Nov; 24(11):1524-1529. PubMed ID: 36254799
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of ventricular repolarization prolongation in resistant hypertension: a prospective cohort study.
Salles GF; Cardoso CR; Muxfeldt ES
J Hypertens; 2009 May; 27(5):1094-101. PubMed ID: 19390353
[TBL] [Abstract][Full Text] [Related]
38. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Oikarinen L; Nieminen MS; Viitasalo M; Toivonen L; Jern S; Dahlöf B; Devereux RB; Okin PM;
Hypertension; 2004 May; 43(5):1029-34. PubMed ID: 15037560
[TBL] [Abstract][Full Text] [Related]
39. Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: the Pamela study.
Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
J Hypertens; 2015 Oct; 33(10):2133-40. PubMed ID: 26196652
[TBL] [Abstract][Full Text] [Related]
40. Left ventricular diastolic dyssynchrony in patients with treatment-naive hypertension and the effects of antihypertensive therapy.
Kwon BJ; Lee SH; Park CS; Kim DB; Park HJ; Jang SW; Ihm SH; Youn HJ; Seung KB; Kim HY
J Hypertens; 2015 Feb; 33(2):354-65. PubMed ID: 25333681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
